??-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension
Authors:
- Markus P SchlaichMSMarkus P Schlaich
- Belinda A AhlersBABelinda A Ahlers
- Melinda M ParnellMPMelinda M Parnell
- David M KayeDKDavid M Kaye
- 1 October 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 22 (10) , 1917-1925
Abstract
It is unknown whether beta-adrenoceptor-mediated vasodilatation is altered in early hypertension and whether it can be modulated by L-arginine. We measured changes in forearm blood flow by plethysmography in response to acetylcholine (9 and 37 microg/min), sodium nitroprusside (200 and 800 ng/min) and the beta-receptor agonist, isoproterenol (50 and 200 ng/min) in 12 patients with essential hypertension (group EH) and in healthy volunteers with (group PFH; n = 14) and without (group NFH; n = 14) a family history of essential hypertension, before and during concomitant infusion of L-arginine (10 micromol/min). In five individuals from each group, infusion of acetylcholine and isoproterenol was repeated during the concurrent blockade of nitric oxide synthesis by N-monomethyl-L-arginine (L-NMMA; 4 micromol/min). The response to acetylcholine was reduced in groups EH and PFH compared with group NFH (both P < 0.05), whereas the vasodilator effects of isoproterenol and sodium nitroprusside were similar in all three groups. Acetylcholine- and isoproterenol-induced vasodilatation did not change during infusion of the nitric oxide precursor, L-arginine, in group NFH, but were significantly enhanced by L-arginine in groups PFH and EH [forearm blood flow before and after isoproterenol 200 ng/min: group PFH 11.8 +/- 1.02 and 13.3 +/- 1.08 ml/min, respectively (P < 0.05); group EH: 11.3 +/- 1.57 and 14.9 +/- 1.91 ml/min, respectively (P < 0.01)]. Co-infusion of L-NMMA blunted the response to acetylcholine and isoproterenol in group NFH (P < 0.05), but did not significantly modify vasodilatation in groups PFH and EH. Although beta-adrenergic vasodilatation seemed to be unaltered in early hypertension, L-arginine enhanced the response to isoproterenol, whereas concomitant inhibition of nitric oxide synthase by L-NMMA had no significant effect. These findings suggest that the nitric oxide component of isoproterenol-mediated vasodilatation is impaired in early hypertension and possibly compensated by increased beta-adrenoceptor responsiveness of smooth muscle cells. In this setting, supplementation of the nitric oxide precursor, L-arginine, enhances the vasodilator response to beta-adrenergic stimulation.Keywords
This publication has 39 references indexed in Scilit:
- Contribution of nitric oxide to β2‐adrenoceptor mediated vasodilatation in human forearm arterial vasculatureBritish Journal of Clinical Pharmacology, 1999
- Decreased Vasodilator Response to Isoproterenol During Nitric Oxide Inhibition in HumansHypertension, 1997
- Effects of Inhibition of thel-Arginine/Nitric Oxide Pathway on Vasodilation Caused by β-Adrenergic Agonists in Human ForearmCirculation, 1997
- Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension.Journal of Clinical Investigation, 1995
- Impaired Endothelium-Dependent Vasodilation in Patients With Essential HypertensionCirculation, 1995
- Nitric oxide synthases: Roles, tolls, and controlsCell, 1994
- Impaired endothelium-dependent vasodilation in patients with essential hypertension: Evidence that the abnormality is not at the muscarinic receptor levelJACC, 1994
- Preserved Endothelium-Dependent Vasodilatation in Patients with Essential HypertensionNew England Journal of Medicine, 1994
- Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential HypertensionNew England Journal of Medicine, 1990
- Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet.Journal of Clinical Investigation, 1990